EXTAVIA

Novartis Pharmaceuticals Corporation🇺🇸 United States

FDA Page

Effective Date: Jul 28, 2023
Approval ID: 4cfdb571-ec4c-478f-bedc-e0669eeea504
Products: 1 registered
Version: 25

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use EXTAVIA safely and effectively. See full prescribing information for EXTAVIA. EXTAVIA (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.